(3aR, 7aS)-N-triphenylmethyl-1,2,3,3a,5,6,7,7a-octahydropyrano[3,2-b]-pyrrol-2-one

DOI: 10.1107/S010827019701158X

Source and publish data:

Acta Crystallographica, Section C: Crystal Structure Communications p. 1971 - 1973 (1997)

Update date:2022-08-05

Topics:

Authors:

Nastopoulos, Vassilios

Gourgioti, Ourania

Balayiannis, George

Karigiannis, George

Papaioannou, Dionissios

Kavounis, Constantin

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1107/S010827019701158X

The title compound, C₂₆H₂₅NO₂, is one of the two main products formed when an inseparable mixture of the diastereomeric (2R,3S)- and (2S,3S)-3-triphenylmethyl-aminooxinan-2-ylacetic acids is treated with N,N′-dicyclohexylc

Full text of DOI:10.1107/S010827019701158X

Products guided by the article

Product name:(3aS,7aS)-1-Trityl-hexahydro-pyrano[3,2-b]pyrrol-2-one

Cas No:299185-44-7

R&D Labs maybe for 299185-44-7

Anhui Hope-Chem Co., Ltd.

Contact:86-551-63540590

Address:No 1388 Furong Rd., Hefei, Anhui, China
ABA Chemicals (Shanghai) Limited

Contact:021- 5115 9199-232

Address:Suite 18D, #201 Ningxia Road,
xuri chemicals co., ltd

Contact:86-516-66656369

Address:The west road of Huaihai, Xuzhou, China
Jinan Decheng Hemu Medical Technology Co.，Ltd.

Contact:+86-531-68650525

Address:NO.554 Zhengfeng Road High-new Technology Development Zone
GrainPlusKft

Contact:36-307-428048

Address:Kulterulet hrsz 09/44, Tatahaza

Relevant to this article

BF₃/MCM-41 as nano structured solid acid catalyst for the synthesis of 3-iminoaryl-imidazo[1,2-a]pyridines

Doi:10.1039/c3cy00947e
(2014)
Congested C₂-symmetric aryliodanes based on an anti-dimethanoanthracene backbone

Doi:10.1039/c2cc32280c
(2012)
Multiple Electrophilic Substitution of 1,1,2,2,9,9,10,10-Octafluoro[2.2]paracyclophane

Doi:10.1021/jo000436x
(2000)
Doi:10.1007/BF00901989
(1977)
Doi:10.1021/ja00722a015
(1970)
Identification and structure-activity relationship of 2-morpholino 6-(3-hydroxyphenyl) pyrimidines, a class of potent and selective PI3 kinase inhibitors

Doi:10.1016/j.bmcl.2010.10.021
(2010)

Article Doi